Monoclonal antibodies and drug conjugates for the treatment of multiple Sclerosis, Alzheimer disease, stroke, traumatic brain injury, long COVID, postoperative cognitive decline, brain B-cell lymphoma, small vessel disease (CADACIL), adrenoleukodystrophy; biological products, namely, monoclonal antibodies for experimental purposes as part of medical treatment for multiple Sclerosis, Alzheimer disease, stroke, traumatic brain injury, long COVID, postoperative cognitive decline, brain B-cell ly...